Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2012 Mar 01;1655:1467-75. doi: 10.1111/j.1476-5381.2011.01626.x.
Show Gene links
Show Anatomy links
TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.
Seyler C, Duthil-Straub E, Zitron E, Gierten J, Scholz EP, Fink RH, Karle CA, Becker R, Katus HA, Thomas D.
???displayArticle.abstract??? TASK1 (K(2P)3.1) two-pore-domain K(+) channels contribute substantially to the resting membrane potential in human pulmonary artery smooth muscle cells (hPASMC), modulating vascular tone and diameter. The endothelin-1 (ET-1) pathway mediates vasoconstriction and is an established target of pulmonary arterial hypertension (PAH) therapy. ET-1-mediated inhibition of TASK1 currents in hPASMC is implicated in the pathophysiology of PAH. This study was designed to elucidate molecular mechanisms underlying inhibition of TASK1 channels by ET-1.Two-electrode voltage clamp and whole-cell patch clamp electrophysiology was used to record TASK1 currents from hPASMC and Xenopus oocytes.ET-1 inhibited TASK1-mediated I(KN) currents in hPASMC, an effect attenuated by Rho kinase inhibition with Y-27632. In Xenopus oocytes, TASK1 current reduction by ET-1 was mediated by endothelin receptors ET(A) (IC(50) = 0.08 nM) and ET(B) (IC(50) = 0.23 nM) via Rho kinase signalling. TASK1 channels contain two putative Rho kinase phosphorylation sites, Ser(336) and Ser(393) . Mutation of Ser(393) rendered TASK1 channels insensitive to ET(A) - or ET(B)-mediated current inhibition. In contrast, removal of Ser(336) selectively attenuated ET(A) -dependent TASK1 regulation without affecting the ET(B) pathway.ET-1 regulated vascular TASK1 currents through ET(A) and ET(B) receptors mediated by downstream activation of Rho kinase and direct channel phosphorylation. The Rho kinase pathway in PASMC may provide a more specific therapeutic target in pulmonary arterial hypertension treatment.
Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011, Pubmed
Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011,
Pubmed Archer,
Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".
2000,
Pubmed Barbuti,
Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor.
2002,
Pubmed Besana,
Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes.
2004,
Pubmed Boureux,
Evolution of the Rho family of ras-like GTPases in eukaryotes.
2007,
Pubmed
,
Xenbase Chemin,
Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels.
2003,
Pubmed Chen,
Inhibition of a background potassium channel by Gq protein alpha-subunits.
2006,
Pubmed Czirják,
TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II.
2000,
Pubmed
,
Xenbase Czirják,
Inhibition of TASK-1 potassium channel by phospholipase C.
2001,
Pubmed
,
Xenbase Dupuis,
Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors.
1996,
Pubmed Galié,
The endothelin system in pulmonary arterial hypertension.
2004,
Pubmed Gardener,
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries.
2004,
Pubmed Gierten,
Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
2008,
Pubmed
,
Xenbase Goldstein,
Potassium leak channels and the KCNK family of two-P-domain subunits.
2001,
Pubmed Gurney,
Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells.
2003,
Pubmed Gurney,
Two-pore potassium channels in the cardiovascular system.
2009,
Pubmed Janssen,
Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase.
2001,
Pubmed Kiesecker,
Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.
2006,
Pubmed
,
Xenbase Lippton,
Functional evidence for different endothelin receptors in the lung.
1993,
Pubmed Lopes,
Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3.
2000,
Pubmed
,
Xenbase Lopes,
PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels.
2005,
Pubmed
,
Xenbase Lüscher,
Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs.
2000,
Pubmed Maingret,
The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.
2001,
Pubmed McMurtry,
Hypoxia and Rho/Rho-kinase signaling. Lung development versus hypoxic pulmonary hypertension.
2003,
Pubmed Miyazaki,
Dynamics of RhoA and ROKalpha translocation in single living cells.
2006,
Pubmed Nagaoka,
Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.
2005,
Pubmed Oleksy,
The molecular basis of RhoA specificity in the guanine nucleotide exchange factor PDZ-RhoGEF.
2006,
Pubmed Olschewski,
Impact of TASK-1 in human pulmonary artery smooth muscle cells.
2006,
Pubmed Priest,
Membrane potential-dependent and -independent vasodilation in small pulmonary arteries from chronically hypoxic rats.
1998,
Pubmed Putzke,
The acid-sensitive potassium channel TASK-1 in rat cardiac muscle.
2007,
Pubmed
,
Xenbase Ridley,
Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking.
2006,
Pubmed Rockman,
Seven-transmembrane-spanning receptors and heart function.
2002,
Pubmed Sakurada,
Rho activation in excitatory agonist-stimulated vascular smooth muscle.
2001,
Pubmed Sato,
[Rho and Rho-kinase].
2006,
Pubmed Seo,
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
1994,
Pubmed Staudacher,
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.
2011,
Pubmed
,
Xenbase Talley,
TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons.
2000,
Pubmed Tang,
Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells.
2009,
Pubmed Thomas,
Alternative translation initiation in rat brain yields K2P2.1 potassium channels permeable to sodium.
2008,
Pubmed
,
Xenbase Thomas,
Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.
1999,
Pubmed
,
Xenbase Van Aelst,
Rho GTPases and signaling networks.
1997,
Pubmed Vincent,
The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization.
1997,
Pubmed Wang,
Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction.
2001,
Pubmed
